Bioneer, Visiopharm, Fluidigm and AH diagnostics are excited to welcome you to this upcoming seminar.
You will be introduced to Fluidigm’s tissue staining and imaging instrument, Hyperion™, that brings CyTOF® technology together with imaging capability to empower simultaneous detection of more than 30 protein markers using Imaging Mass Cytometry™ (IMC™). The assembly of molecular information together with the histology context is considered key in e.g. precision medicine. You will also be introduced to Visiopharm’s novel evaluation tool called Phenomap™ Multiplexing that handles the multiple image stacks from the Hyperion to provide quantitative output.
The seminar aims at gathering researchers and peers from academia and pharmaceutical industry as well as clinicians within diagnostic pathology and oncology, to learn about these novel technology platforms and the potential implications for future scientific discoveries and clinical applications.
Interested in attending the event, please register at the following link.
For more information about the event or related topics, please contact R&D manager in Molecular Histology Boye Schnack Nielsen (email) or Business Development Manager Lovisa M. Sunesson (email).